HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation between DNA ploidy and clinical features in smooth muscle tumors of the gastrointestinal tract.

Abstract
Paraffin-embedded tissue samples from 51 surgically resected, gastrointestinal smooth muscle tumors (10 leiomyomas, 5 leiomyoblastomas and 36 leiomyosarcomas) were assayed for nuclear DNA content, and the results were examined for correlation with clinico-pathological variables (tumor size, cellularity and mitosis) and prognosis. Twenty-four (47%) of the 51 tumors, consisting of 3 (30%) of the 10 leiomyomas, 2 (40%) of the 5 leiomyoblastomas and 19 (53%) of the 36 leiomyosarcomas, were identified as aneuploid. A close correlation was found between the mitotic index and the tumor size (<cc> = 0.528; P < 0.001). The DNA ploidy pattern of the leiomyosarcoma was closely correlated with the patient survival periods (P = 0.06). The estimated median survival period was 73 months for patients with diploid tumors, and 51 months for those with aneuploid tumors. The 10-year survival rate for aneuploid tumors was lower than that for diploid tumors (P < 0.001). The measurement of DNA content may provide an index of prognostic value in gastrointestinal leiomyosarcomas.
AuthorsH Kimura, Y Yonemura, N Kadoya, T Kosaka, K Miwa, I Miyazaki, T Sawa, S Yoshimitsu, Y Nishida, T Kamata
JournalAnalytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology (Anal Cell Pathol) Vol. 5 Issue 6 Pg. 331-8 (Nov 1993) ISSN: 0921-8912 [Print] Netherlands
PMID8305329 (Publication Type: Journal Article)
Chemical References
  • DNA, Neoplasm
Topics
  • Adult
  • Aged
  • DNA, Neoplasm (analysis, genetics)
  • Female
  • Gastrointestinal Neoplasms (genetics, pathology)
  • Humans
  • Leiomyoma (genetics, pathology)
  • Leiomyoma, Epithelioid (genetics, pathology)
  • Leiomyosarcoma (genetics, pathology)
  • Male
  • Middle Aged
  • Muscle, Smooth
  • Ploidies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: